Risk of dipeptidyl peptidase-4 (DPP-4) inhibitors on site-specific cancer: A systematic review and meta-analysis-Reference-Cited by-同舟云学术

Risk of dipeptidyl peptidase-4 (DPP-4) inhibitors on site-specific cancer: A systematic review and meta-analysis

Published:2018-04-26 Issue:5 Volume:34 Page:e3004
ISSN:1520-7552
Container-title:Diabetes/Metabolism Research and Reviews
language:en
Short-container-title:Diabetes Metab Res Rev

Author:

Overbeek Jetty A.¹²^ORCID,Bakker Marina²,van der Heijden Amber A.W.A.¹,van Herk-Sukel Myrthe P.P.³,Herings Ron M.C.²⁴,Nijpels Giel¹

Affiliation:

1. Department of General Practice and Elderly Care Medicine, Amsterdam Public Health Research Institute; VU University Medical Centre; Amsterdam Netherlands

2. PHARMO Institute for Drug Outcomes Research; Utrecht Netherlands

3. Department of Internal Medicine and Dermatology; University Medical Center Utrecht; Utrecht Netherlands

4. Department of Epidemiology and Biostatistics; VU University Medical Center; Amsterdam Netherlands

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference51 articles.

1. A critical analysis of the clinical use of incretin-based therapies: are the GLP-1 therapies safe?;Butler;Diabetes Care,2013

2. Pancreatitis, pancreatic, and thyroid cancer with glucagon-like peptide-1-based therapies;Elashoff;Gastroenterology,2011

3. Cancer adverse events associated with dipeptidyl peptidase 4 inhibitors: data mining of public FDA adverse event reporting system;Feng;Pharmacotherapy,2012

4. Pancreatic safety of incretin-based drugs-FDA and EMA assessment;Egan;The New England Journal of Medicine,2014

5. A meta-analysis of serious adverse events reported with exenatide and liraglutide: acute pancreatitis and cancer;Alves;Diabetes Research and Clinical Practice,2012

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pancreatitis and Pancreatic Cancer Risk Among Patients With Type 2 Diabetes Receiving Dipeptidyl Peptidase 4 Inhibitors: An Updated Meta-Analysis of Randomized Controlled Trials;Clinical Therapeutics;2024-08

2. Non-genetic factors and breast cancer: an umbrella review of meta-analyses;BMC Cancer;2024-07-26

3. Incretin-based drugs decrease the incidence of prostate cancer in type 2 diabetics: A pooling-up analysis;Medicine;2024-05-17

4. Therapy of Type 2 Diabetes;Experimental and Clinical Endocrinology & Diabetes;2024-04-10

5. Therapie des Typ-2-Diabetes;Die Diabetologie;2024-01-30